TrialHaematologica2019

Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia.

Michael Steurer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.